CoChat

The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer’s and Parkinson’s Diseases

Romero, K, de Mars, M, Frank, D, Anthony, M, Neville, J, Kirby, L, Smith, K, Woosley, R L · 2009 · Clinical Pharmacology & Therapeutics
Cited by 55

The DOI matches its Crossref record.

Abstract

Aiming to emulate the successful accelerated development of HIV/AIDS drugs, the Critical Path Institute (C-Path), in collaboration with the Engelberg Center for Health Care Reform at the Brookings Institution, has formed the Coalition Against Major Diseases (CAMD). Members include 6 nonprofit groups representing patients' interests, 15 leading pharmaceutical companies, the US Food and Drug Administration (FDA), the European Medicines Agency (EMEA), 2 institutes of the National Institutes of Health (NIH)-the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS)-and representatives from academia. The coalition's purpose is to transform the drug development paradigm for neurodegenerative diseases and serve as a model for other major diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/clpt.2009.165

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 55

Metadata

Authors
Romero, K., de Mars, M., Frank, D., Anthony, M., Neville, J., Kirby, L., Smith, K., & Woosley, R. L.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2009-10
Volume
86
Issue
4
Pages
365-367
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W1988607226
Cited by
55
References
0
FWCI
3.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer’s and Parkinson’s Diseases. https://app.cochat.ai/papers/10.1038/clpt.2009.165
The paper
Romero, K., de Mars, M., Frank, D., Anthony, M., Neville, J., Kirby, L., Smith, K., & Woosley, R. L. (2009). The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer’s and Parkinson’s Diseases. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.2009.165

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.